My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 137

    1.

    Five stages of evolving beta-cell dysfunction during progression to diabetes.

    Weir GC, Bonner-Weir S.

    Diabetes. 2004 Dec;53 Suppl 3:S16-21. Review.PMID: 15561905 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Beta-cell adaptation and decompensation during the progression of diabetes.

    Weir GC, Laybutt DR, Kaneto H, Bonner-Weir S, Sharma A.

    Diabetes. 2001 Feb;50 Suppl 1:S154-9. Review.PMID: 11272180 [PubMed - indexed for MEDLINE]Related articles

    3.

    The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus.

    Kahn SE.

    Am J Med. 2000 Apr 17;108 Suppl 6a:2S-8S. Review.PMID: 10764844 [PubMed - indexed for MEDLINE]Related articles

    4.

    Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance.

    Mauvais-Jarvis F, Sobngwi E, Porcher R, Riveline JP, Kevorkian JP, Vaisse C, Charpentier G, Guillausseau PJ, Vexiau P, Gautier JF.

    Diabetes. 2004 Mar;53(3):645-53.PMID: 14988248 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Pathophysiology of insulin secretion.

    Scheen AJ.

    Ann Endocrinol (Paris). 2004 Feb;65(1):29-36. Review.PMID: 15122089 [PubMed - indexed for MEDLINE]Related articles

    6.

    Irreversibility of nutritionally induced NIDDM in Psammomys obesus is related to beta-cell apoptosis.

    Bar-On H, Ben-Sasson R, Ziv E, Arar N, Shafrir E.

    Pancreas. 1999 Apr;18(3):259-65.PMID: 10206484 [PubMed - indexed for MEDLINE]Related articles

    7.

    Abnormalities in insulin secretion in type 2 diabetes mellitus.

    Guillausseau PJ, Meas T, Virally M, Laloi-Michelin M, Médeau V, Kevorkian JP.

    Diabetes Metab. 2008 Feb;34 Suppl 2:S43-8. Review.PMID: 18640585 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    [Early stages of beta-cell deficiency: the anticipated chronicle to type 2 diabetes]

    Vialettes B, Valéro R.

    Diabetes Metab. 2003 Apr;29(2 Pt 3):S11-5. Review. French. PMID: 12746615 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Dynamic changes in {beta}-cell mass and pancreatic insulin during the evolution of nutrition-dependent diabetes in psammomys obesus: impact of glycemic control.

    Kaiser N, Yuli M, Uçkaya G, Oprescu AI, Berthault MF, Kargar C, Donath MY, Cerasi E, Ktorza A.

    Diabetes. 2005 Jan;54(1):138-45.PMID: 15616021 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The pathophysiological basis for intensive insulin replacement.

    Rolla A.

    Int J Obes Relat Metab Disord. 2004 Sep;28 Suppl 2:S3-7. Review.PMID: 15306831 [PubMed - indexed for MEDLINE]Related articles

    11.

    Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.

    Festa A, Williams K, Hanley AJ, Haffner SM.

    Diabetes. 2008 Jun;57(6):1638-44. Epub 2008 Mar 10.PMID: 18332099 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    [Early changes in the function of pancreatic beta cells and insulin pulsatility as predictors of type 2 diabetes]

    Pørksen N.

    Diabetes Metab. 1999 Dec;25 Suppl 7:14-6. French. PMID: 10746005 [PubMed - indexed for MEDLINE]Related articles

    13.

    Insulin resistance causes increased beta-cell mass but defective glucose-stimulated insulin secretion in a murine model of type 2 diabetes.

    Asghar Z, Yau D, Chan F, Leroith D, Chan CB, Wheeler MB.

    Diabetologia. 2006 Jan;49(1):90-9. Epub 2005 Dec 15. Erratum in: Diabetologia. 2006 Mar;49(3):614. PMID: 16362284 [PubMed - indexed for MEDLINE]Related articles

    14.

    Coordinate changes in plasma glucose and pancreatic beta-cell function in Latino women at high risk for type 2 diabetes.

    Xiang AH, Wang C, Peters RK, Trigo E, Kjos SL, Buchanan TA.

    Diabetes. 2006 Apr;55(4):1074-9.PMID: 16567531 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Decreased insulin secretion in type 2 diabetes: a problem of cellular mass or function?

    Clark A, Jones LC, de Koning E, Hansen BC, Matthews DR.

    Diabetes. 2001 Feb;50 Suppl 1:S169-71.PMID: 11272183 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Type 2 diabetes and beta cell apoptosis]

    Cerasi E, Kaiser N, Leibowitz G.

    Diabetes Metab. 2000 Jun;26 Suppl 3:13-6. Review. French. PMID: 10945145 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes.

    Kahn SE.

    Diabetologia. 2003 Jan;46(1):3-19. Epub 2003 Jan 11. Review.PMID: 12637977 [PubMed - indexed for MEDLINE]Related articles

    18.

    Incorporation of beta cell redifferentiation therapy into a lipoprivic strategy for reversing type 2 diabetes.

    McCarty MF.

    Med Hypotheses. 2002 Jun;58(6):462-71.PMID: 12323111 [PubMed - indexed for MEDLINE]Related articles

    19.

    [The pathogenesis of type 2 diabetes--new aspects and clinical consequences]

    Donath MY, Maedler K, Sergeev P, Dyntar D, Thomas D, Spinas GA.

    Ther Umsch. 2002 Aug;59(8):381-5. German. PMID: 12235729 [PubMed - indexed for MEDLINE]Related articles

    20.

    Glucotoxicity and beta-cell failure in type 2 diabetes mellitus.

    Kaiser N, Leibowitz G, Nesher R.

    J Pediatr Endocrinol Metab. 2003 Jan;16(1):5-22. Review.PMID: 12585335 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity